PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
24-Sep-2020 Zuhlke supported the development and launch of the new NHS Covid-19 app for England & Wales Zuhlke
24-Sep-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics raises $96m in ‘Series B’ Financing ICR and Cancer Research UK
24-Sep-2020 Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses Algenex SL
24-Sep-2020 Coeliac UK wins national award for its Gluten Free on the Move app - winning the category for the second year in a row Coeliac UK
24-Sep-2020 Vifor Pharma announces outcome of AFFIRM-AHF topline data Vifor Pharma
24-Sep-2020 GLEAMER raises € 7.5 million to market A.I. platform offering radiologists semi-automated diagnosis of medical images GLEAMER
24-Sep-2020 MMS and Pharmacy Automation is Easing the Pressure During COVID-19 Becton, Dickinson and Company
24-Sep-2020 Coeliac UK wins national award for its Gluten Free on the Move app Coeliac UK
23-Sep-2020 Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics
23-Sep-2020 Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn Aqualung Therapeutics
23-Sep-2020 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020 Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial AstraZeneca
23-Sep-2020 PureTech Plans U.S. Listing on Nasdaq Global Market PureTech Health
23-Sep-2020 Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) Helsinn
22-Sep-2020 Roxtec supplies seals for hazardous areas to pharmaceutical group Guerbet during Dublin site upgrade Roxtec UK & Ireland
21-Sep-2020 Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50% Sanofi
21-Sep-2020 ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION Abbott
21-Sep-2020 Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020 Genmab
18-Sep-2020 Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020 Envision Pharma Group
18-Sep-2020 SciBite launches state-of-the-art AI platform for Life Sciences organisations SciBite